当前位置: X-MOL 学术J. Control. Release › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Lu3+-based nanoprobe for virtual non-contrast CT imaging of hepatocellular carcinoma
Journal of Controlled Release ( IF 10.8 ) Pub Date : 2022-07-12 , DOI: 10.1016/j.jconrel.2022.06.055
Jiayao Chen , Jiani Liu , Duo Xu , Junfeng Liu , Xiaojun Chen , Shuai Yang , Pan Yin , Zebo Jiang , Chaoming Mei , Xiaoting Zhang , Lizhu Wang , Ke Zhang , Bin Zhou , Hong Shan , Dan Li , Pengfei Pang

Transcatheter arterial chemoembolization (TACE), the mainstream treatment for hepatocellular carcinoma (HCC), is a method of blocking tumor blood vessels with a mixture of lipiodol and chemotherapeutics. And the contrast-enhanced computed tomography (CT) is the commonly used way for follow-up of HCC after TACE. However, it is noteworthy that when lipiodol deposition plays an embolic effect, it also produces high-density artifacts in CT images. These artifacts usually conceal the enhancement effect of iodine contrast agents. As a result, the residual region is difficult to be visualized. To overcome this obstacle, we developed one kind of Lu3+/Gd3+ doped fluoride nanoprobe modified with Dp-PEG2000 to realize CT/MRI dual-modality imaging of HCC. Compared with lipiodol or ioversol, the obtained PEGylated product LG-PEG demonstrated a greater density value in high keV CT images. In vitro experiments showed the lipiodol artifacts can be removed in virtual non-contrast (VNC) imaging, but the density of ioversol was also removed at the same time. However, the LG-PEG synthesized in this work can still maintain a high density in VNC imaging, which indicates that LG-PEG can exploit its advantages to the full in VNC imaging. Furthermore, LG-PEG successfully exerted tumor enhancement effects in the in vivo VNC images of HCC with lipiodol deposition. In addition, LG-PEG exhibited a strong T2 enhancement effect with low biological toxicity and less side-effect on the main organ and blood. Thus, the LG-PEG reported in this research can serve as an effective and safe VNC contrast agent for HCC imaging after TACE.



中文翻译:

基于 Lu3+ 的纳米探针用于肝细胞癌的虚拟平扫 CT 成像

经导管动脉化疗栓塞术 (TACE) 是肝细胞癌 (HCC) 的主流治疗方法,是一种使用碘油和化疗药物的混合物阻断肿瘤血管的方法。而对比增强计算机断层扫描(CT)是TACE后HCC随访的常用方法。但值得注意的是,当碘油沉积起到栓塞作用时,也会在 CT 图像中产生高密度伪影。这些伪影通常掩盖了碘造影剂的增强效果。结果,残留区域难以可视化。为了克服这个障碍,我们开发了一种Lu 3+ /Gd 3+Dp-PEG2000修饰掺杂氟化物纳米探针实现HCC CT/MRI双模态成像[J]. 与碘油或碘佛醇相比,所得聚乙二醇化产物LG-PEG在高keV CT图像中表现出更大的密度值。体外实验表明,在虚拟非对比(VNC)成像中可以去除碘油伪影,但同时也去除了碘佛醇的密度。然而,本工作合成的 LG-PEG 在 VNC 成像中仍然可以保持高密度,这表明 LG-PEG 可以在 VNC 成像中充分发挥其优势。此外,LG-PEG 在具有碘油沉积的 HCC的体内VNC 图像中成功地发挥了肿瘤增强作用。此外,LG-PEG表现出很强的T 2增强作用,生物毒性低,对主要器官和血液的副作用小。因此,本研究报道的 LG-PEG 可作为 TACE 后 HCC 成像的有效且安全的 VNC 造影剂。

更新日期:2022-07-12
down
wechat
bug